American Medical Women's Association's commitment to advancing menopausal health equity and awareness - Report - MDSpire

American Medical Women's Association's commitment to advancing menopausal health equity and awareness

  • By

  • Meghan Etsey

  • Rhea Manohar

  • Aida Mansour

  • Leah Liszak

  • Chelsea Oppong

  • Sarv Raafati

  • Kiana Wells

  • Vashti Price

  • Vaishnavi J. Patel

  • Teresa Lazar

  • Ariela L. Marshall

  • Rosy Thachil

  • Brianna Clark

  • Roberta Gebhard

  • July 3, 2026

  • 0 min

Share

Advancing Health Equity and Awareness in Menopause: The Role of AMWA

Background

Menopause is a significant phase of health that impacts millions of women, yet it remains underrecognized in clinical practice. The lack of awareness and education surrounding menopause contributes to disparities in healthcare. Addressing menopause equity is essential for improving quality of life and preventing health complications for those affected.

Data Highlights

No numerical data was provided in the source material.

Key Findings

  • Menopause equity involves fair recognition and support for individuals experiencing menopause across various contexts.
  • Approximately 60 million women in the U.S. are postmenopausal, with nearly 10 million undergoing the menopausal transition.
  • Menopause-related symptoms can lead to increased workplace discrimination and adverse health outcomes.
  • Access to workplace accommodations is crucial for preventing injuries and supporting professional longevity during menopause.

Clinical Implications

Healthcare providers should prioritize menopause education and awareness to improve care for patients experiencing menopause.

Conclusion

Advancing menopause equity is vital for ensuring comprehensive care and support for individuals navigating this life stage.

Related Resources & Content

  1. American Medical Women's Association, Advancing Health Equity and Awareness in Menopause, 2023 -- Title
  2. conexiant — Rethinking Menopause Hormone Therapy
  3. Journal of Medical Internet Research (JMIR) — Women’s Engagement With Different Internet-Enabled Technologies to Access Digital Menopause Information: Mixed Methods, Multiphase Sequential Study
  4. Stat News — STAT readers on MAHA activists, perimenopause, and diversity in medical school
  5. Nature Reviews Endocrinology — Menopause in the spotlight: important research and clinical advances
  6. Rethinking Menopause Hormone Therapy
  7. Women’s Engagement With Different Internet-Enabled Technologies to Access Digital Menopause Information
  8. Menopause: identification and management Guidance
  9. Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline
  10. https://academic.oup.com/ejendo/article/193/4/G49/8281862?login=false
  11. Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause
  12. Menopausal Hormone Therapy and Cardiovascular Diseases in Women With Vasomotor Symptoms: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trials | Reproductive Health | JAMA Internal Medicine | JAMA Network
  13. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products | FDA
  14. Inequalities in hormone replacement therapy prescribing in UK primary care: population based cohort study | BMJ Medicine
  15. Health Disparities and Hormone Therapy Prescribing for Early, Peri-, and Postmenopausal Women: A Scoping Review - PubMed

Original Source(s)

American Medical Women's Association's commitment to advancing menopausal health equity and awareness

  • by Meghan Etsey, Rhea Manohar, Aida Mansour, Leah Liszak, Chelsea Oppong, Sarv Raafati, Kiana Wells, Vashti Price, Vaishnavi J. Patel, Teresa Lazar, Ariela L. Marshall, Rosy Thachil, Brianna Clark, Roberta Gebhard

  • July 3, 2026

Related Content

Online Menopause Information–Seeking Search Patterns and Commercial Content Over 2 Decades

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Menopause and ageing in women with multiple sclerosis